These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1910125)

  • 21. Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.
    Sprengers ED; Verheijen JH; Van Hinsbergh VW; Emeis JJ
    Biochim Biophys Acta; 1984 Sep; 801(2):163-70. PubMed ID: 6541058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities.
    Sitrin RG; Brubaker PG; Fantone JC
    Am Rev Respir Dis; 1987 Apr; 135(4):930-6. PubMed ID: 3565941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasminogen activator inhibitor-1 is a significant determinant of renal injury in experimental crescentic glomerulonephritis.
    Kitching AR; Kong YZ; Huang XR; Davenport P; Edgtton KL; Carmeliet P; Holdsworth SR; Tipping PG
    J Am Soc Nephrol; 2003 Jun; 14(6):1487-95. PubMed ID: 12761249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary crosslinked fibrin degradation products in glomerular disease.
    Kamitsuji H; Whitworth JA; Dowling JP; Kincaid-Smith P
    Am J Kidney Dis; 1986 Jun; 7(6):452-5. PubMed ID: 3717150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of proteins and fibrinolysis in patients with glomerulonephritis.
    Wardle EN; Menon IS; Rastogi SP
    Br Med J; 1970 May; 2(5704):260-3. PubMed ID: 4246192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased fibrin formation and impaired fibrinolytic capacity in severe chronic kidney disease.
    Mörtberg J; Blombäck M; Wallén Å; He S; Jacobson SH; Spaak J
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):401-7. PubMed ID: 26650459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two different mechanisms in patients with venous thrombosis and defective fibrinolysis: low concentration of plasminogen activator or increased concentration of plasminogen activator inhibitor.
    Nilsson IM; Ljungnér H; Tengborn L
    Br Med J (Clin Res Ed); 1985 May; 290(6480):1453-6. PubMed ID: 3922531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The venous occlusion test in assessing the fibrinolytic activity of the vascular endothelium in lupus nephritis patients].
    Bobkova IN; Poliantseva LR; Tareeva IE; Andreenko GV; Podorol'skaia LV
    Ter Arkh; 1995; 67(4):42-5. PubMed ID: 7784974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diurnal variation of the fibrinolytic system.
    Grimaudo V; Hauert J; Bachmann F; Kruithof EK
    Thromb Haemost; 1988 Jun; 59(3):495-9. PubMed ID: 3142085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glomerular coagulation system in renal diseases.
    Kanfer A
    Ren Fail; 1992; 14(3):407-12. PubMed ID: 1509174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1999; 45(2):158-64. PubMed ID: 10378306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glomerular fibrinolytic activity in anti-GBM glomerulonephritis in rabbits.
    Malliaros J; Holdsworth SR; Wojta J; Erlich J; Tipping PG
    Kidney Int; 1993 Sep; 44(3):557-64. PubMed ID: 8231028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.
    de Jong E; Porte RJ; Knot EA; Verheijen JH; Dees J
    Gut; 1989 Feb; 30(2):188-94. PubMed ID: 2495239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on coagulation fibrinolytic systems in predialysis patients with chronic renal failure--comparison between patients with chronic glomerulonephritis and patients with diabetic nephropathy].
    Nagake Y; Makino H; Yorioka N; Nomura S; Osawa G; Yamakido M; Kawasaki H; Kato Y; Matsuzaki M; Shikata K; Uemasu J; Somiya H; Fujii Z; Hayashida S; Nasu T; Oyabu Y; Nitta Y; Kawanishi H; Usui K; Fujiwara K; Takasugi N; Kanehara K; Hamaguchi N; Kumagai I; Ota Z
    Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):474-82. PubMed ID: 9283213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies of fibrinolytic activity of uremic and longterm hemodialytic patients with special reference to fibrinolytic inhibitor.
    Homma T; Ichikawa T
    Biochem Exp Biol; 1979; 15(3):229-36. PubMed ID: 122165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procoagulant and fibrinolytic activity of human ovarian carcinoma cells in culture.
    Mussoni L; Conforti G; Gambacorti-Passerini C; Alessio G; Pepe S; Vaghi M; Erba E; Amato G; Landoni F; Mangioni C
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):373-80. PubMed ID: 3732346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Levels of three hemostatic factors in relation to serum lipids. Monocyte procoagulant activity, tissue plasminogen activator, and type-1 plasminogen activator inhibitor.
    Crutchley DJ; McPhee GV; Terris MF; Canossa-Terris MA
    Arteriosclerosis; 1989; 9(6):934-9. PubMed ID: 2511826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
    Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
    Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.